0 Datasets
0 Files
Get instant academic access to this publication’s datasets.
Join our academic network to download verified datasets and collaborate with researchers worldwide.
Get Free AccessIn people with type 2 diabetes with nephropathy, valsartan (320 mg/d) safely postponed ESRD more effectively than benazepril (20 mg/d) or than halved doses of both medications.
Piero Ruggenenti, Matias Trillini, Draženka Pongrac Barlovič, Monica Cortinovis, Antonio Pisani, Aneliya Parvanova, Ilian Iliev, Barbara Ruggiero, Stefano Rota, M Aparicio, Annalisa Perna, Francesco Peraro, Olimpia Diadei, Flavio Gaspari, Fabiola Carrara, Nadia Stucchi, Davide Martinetti, Andrej Janež, Nadan Gregorič, Eleonora Riccio, Antonio Bossi, Roberto Trevisan, Paolo Manunta, Giovanni Giorgio Battaglia, S. David, Filippo Aucella, Antonio Belviso, Andrea Satta, Giuseppe Remuzzi (2019). Effects of valsartan, benazepril and their combination in overt nephropathy of type 2 diabetes: A prospective, randomized, controlled trial. , 21(5), DOI: https://doi.org/10.1111/dom.13639.
Datasets shared by verified academics with rich metadata and previews.
Authors choose access levels; downloads are logged for transparency.
Students and faculty get instant access after verification.
Type
Article
Year
2019
Authors
29
Datasets
0
Total Files
0
Language
en
DOI
https://doi.org/10.1111/dom.13639
Access datasets from 50,000+ researchers worldwide with institutional verification.
Get Free AccessYes. After verification, you can browse and download datasets at no cost. Some premium assets may require author approval.
Files are stored on encrypted storage. Access is restricted to verified users and all downloads are logged.
Yes, message the author after sign-up to request supplementary files or replication code.
Join 50,000+ researchers worldwide. Get instant access to peer-reviewed datasets, advanced analytics, and global collaboration tools.
✓ Immediate verification • ✓ Free institutional access • ✓ Global collaboration
.webp){kind=avatar}
